Zhang Yongsheng, Xu Yanjiao, Zhang Yanping, Wang Shoushi, Zhao Mingqiang
Qingdao Medical College, Qingdao University, Qingdao, Shandong, China.
Department of Anesthesia and Perioperative Medicine, Qingdao Central Hospital, University of Health and Rehabilitation Sciences, Qingdao, Shandong, China.
Front Pharmacol. 2025 Mar 28;16:1559408. doi: 10.3389/fphar.2025.1559408. eCollection 2025.
Breast cancer (BC) is a malignant tumor that has the highest morbidity and mortality rates in the female population, and its high tendency to metastasize is the main cause of poor clinical prognosis. Long non-coding RNAs (lncRNAs) have been extensively documented to exhibit aberrant expression in various cancers and influence tumor progression via multiple molecular pathways. These lncRNAs not only modulate numerous aspects of gene expression in cancer cells, such as transcription, translation, and post-translational modifications, but also play a crucial role in the reprogramming of energy metabolism by regulating metabolic regulators, which is particularly significant in advanced BC. This review examines the characteristics and mechanisms of lncRNAs in regulating BC cells, both intracellularly (e.g., cell cycle, autophagy) and extracellularly (e.g., tumor microenvironment). Furthermore, we explore the potential of specific lncRNAs and their regulatory factors as molecular markers and therapeutic targets. Lastly, we summarize the application of lncRNAs in the treatment of advanced BC, aiming to offer novel personalized therapeutic options for patients.
乳腺癌(BC)是女性群体中发病率和死亡率最高的恶性肿瘤,其高转移倾向是临床预后不良的主要原因。长期以来,大量研究表明长链非编码RNA(lncRNAs)在各种癌症中呈现异常表达,并通过多种分子途径影响肿瘤进展。这些lncRNAs不仅调节癌细胞中基因表达的众多方面,如转录、翻译和翻译后修饰,还通过调节代谢调节因子在能量代谢重编程中发挥关键作用,这在晚期乳腺癌中尤为重要。本综述探讨了lncRNAs在细胞内(如细胞周期、自噬)和细胞外(如肿瘤微环境)调节乳腺癌细胞的特征和机制。此外,我们还探讨了特定lncRNAs及其调节因子作为分子标志物和治疗靶点的潜力。最后,我们总结了lncRNAs在晚期乳腺癌治疗中的应用,旨在为患者提供新的个性化治疗选择。